PercuSurge GuardWire Initial Studies Show Device Safe And Effective - TCT
This article was originally published in The Gray Sheet
Larger, randomized studies of PercuSurge's GuardWire system should be performed to further substantiate initial, positive study results showing that use of the system in conjunction with carotid angioplasty and stenting help protect the brain from cerebral embolism, investigators say.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.